Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

12.32

-0.23 (-1.83%)

At close: Feb 4, 2026, 4:00 PM EST

12.08

-0.24 (-1.95%)

After-hours: Feb 4, 2026, 4:59 PM EST

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,659	332	1,010	639	958	-
Market Cap Growth	441.98%	-67.13%	57.94%	-33.25%	-	-
Enterprise Value	1,526	76	689	287	461	-
Last Close Price	12.55	3.09	9.90	7.25	10.94	11.44
PS Ratio	20.86	7.89	27.64	25.72	25.86	-
PB Ratio	8.75	1.66	3.99	2.56	2.78	-
P/TBV Ratio	10.28	1.66	3.99	2.56	2.78	-
EV/Sales Ratio	22.95	1.81	18.87	11.53	12.45	-
Debt / Equity Ratio	0.22	0.18	0.15	0.17	0.00	0.20
Debt / FCF Ratio	-	-	-	-	-	0.11
Asset Turnover	0.24	0.12	0.09	0.05	0.11	0.06
Quick Ratio	8.29	6.76	7.33	6.63	11.98	4.70
Current Ratio	8.88	6.98	7.54	6.76	12.10	4.73
Return on Equity (ROE)	-51.65%	-57.58%	-40.49%	-36.41%	-30.38%	-223.51%
Return on Assets (ROA)	-24.52%	-25.31%	-17.01%	-14.82%	-10.28%	-24.81%
Return on Capital Employed (ROCE)	-57.60%	-52.30%	-32.00%	-29.20%	-12.70%	-31.40%
Earnings Yield	-6.11%	-39.26%	-10.08%	-16.92%	-6.08%	-
FCF Yield	-8.93%	-39.85%	-11.84%	-18.27%	-6.41%	-
Buyback Yield / Dilution	-2.50%	-15.50%	-7.69%	-41.40%	-94.50%	-255.37%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q